Focue Provides the Latest and Most Up-to-Date News, What You Focus On is What You Get.
⎯ 《 Focue • Com 》
ECB hikes key rate to record high, defying calls for pause
ECB hikes key rate to record high, defying calls for pause
The European Central Bank hiked a key interest rate to a record high Thursday as it battles soaring inflation, defying calls for a pause to take...
2023-09-14 20:48
GTA Online May Racing Bonuses Lineup Announced
GTA Online May Racing Bonuses Lineup Announced
Here's a breakdown of the race bonuses lineup going live in GTA Online this month.
1970-01-01 08:00
11 Movies to Get You Into the Thanksgiving Spirit
11 Movies to Get You Into the Thanksgiving Spirit
Before diving into Christmas content, don't forget to add these Thanksgiving movies to your watchlist.
2023-11-08 22:32
Options Bolsters Digital Transformation Capabilities as Microsoft Solutions Partner
Options Bolsters Digital Transformation Capabilities as Microsoft Solutions Partner
LONDON & NEW YORK & HONG KONG--(BUSINESS WIRE)--Sep 28, 2023--
2023-09-28 17:41
Charting the Global Economy: Weak Trade Shows China Struggling
Charting the Global Economy: Weak Trade Shows China Struggling
Fresh trade data out of China added to evidence that the world’s second-largest economy is struggling for traction.
2023-06-10 17:00
PepsiCo returns to Indonesia, breaks ground for snack factory
PepsiCo returns to Indonesia, breaks ground for snack factory
By Stefanno Sulaiman CIKARANG, Indonesia U.S. food and beverage maker PepsiCo began building a snack factory in Indonesia's
2023-08-30 12:17
Charli D'Amelio: Here are 5 tips to help you stay in shape like TikTok star
Charli D'Amelio: Here are 5 tips to help you stay in shape like TikTok star
Let's take a cue from this fitness icon who is inspiring all of us to take care of ourselves and to strive for our own best versions
1970-01-01 08:00
Hopes for change in Gabon after years of unpaid pensions
Hopes for change in Gabon after years of unpaid pensions
There's a new air of optimism among the seniors waiting patiently since dawn in Gabon's capital Libreville to chase up...
2023-09-14 20:22
Rhea Ripley reveals why Logan Paul and Bad Bunny have done so well in WWE
Rhea Ripley reveals why Logan Paul and Bad Bunny have done so well in WWE
Both Bad Bunny and Logan Paul have impressed WWE audiences since making their in-ring debuts and now WWE Women's World Champion Rhea Ripley has revealed why both celebrities have found so much success in wrestling. "Bad Bunny, he loves WWE. He watched it growing up, he loves everything about it, like he's a true fan. So him coming into WWE, I didn't really have a problem with because you could see the passion behind it. Like he was so excited, he trained, he got better, and he just like persevered and wanted to have a fantastic match. And him and Damian Priest, I want to say, had the best match at Backlash. It was absolutely insane. Sign up to our free Indy100 weekly newsletter "And then Logan Paul, he is such an athlete. Yes, he's not around as much and I'm not entirely sure how much he does love the business, but there's that little bit of passion where you could see how excited he gets when he is in the ring and that's cool to see. "So whoever it is that comes in next, I don't know who I would want to come in as long as they respect the business and they have passion behind it because so many of us dedicate years of our life and throw away time with our family to be here doing the one thing that we love. So a little bit of respect on the wrestling world would be fantastic."‘ WWE brings Money In The Bank to The O2 in London on Saturday 1st July. For tickets visit: https://www.wwe.com/event/money-in-the-bank. Fans can tune in on the WWE Network.’Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings.
2023-06-30 15:46
Marketmind: No respite from China woes
Marketmind: No respite from China woes
A look at the day ahead in European and global markets from Ankur Banerjee Before investors get consumed by the
2023-08-10 12:39
Ozempic users report stomach paralysis as weight loss drug side effect: ‘I wish I never touched it’
Ozempic users report stomach paralysis as weight loss drug side effect: ‘I wish I never touched it’
A recent investigation has found that some Ozempic and Wegovy patients suffered from severe gastroparesis, also known as stomach paralysis, after taking the medications. In a report from CNN published on 25 July, two patients reported that their “stomachs are paralysed” after taking type 2 diabetes drug Ozempic – a semaglutide injection known for its weight loss side effects. “I wish I never touched it. I wish I’d never heard of it in my life,” Joanie Knight, a 37-year-old from Louisiana, told CNN. “This medicine made my life hell. So much hell. It has cost me money. It cost me a lot of stress; it cost me days and nights and trips with my family. It’s cost me a lot, and it’s not worth it. The price is too high.” Emily Wright, a 38-year-old teacher from Toronto, said she vomits so frequently that she had to take a leave of absence from her job. “I’ve almost been off Ozempic for a year, but I’m still not back to my normal,” she said. According to CNN, both women have been diagnosed with severe gastroparesis, a disorder that slows or stops the movement of food from the stomach to the small intestine, per the Mayo Clinic. Wright has also been diagnosed with cyclic vomiting syndrome, which causes her to throw up multiple times a day. Meanwhile, one Wegovy user claimed she began experiencing stomach problems after her doctor prescribed her the weight loss drug – which works by mimicking a hormone called glucagon-like peptide 1 (GLP-1), regulating blood sugar levels and slowing down the rate at which food leaves the stomach to create the feeling of fullness. However, the medication caused her to vomit so much that she became dehydrated and needed to visit urgent care. Brenda Allen, from Texas, has since been managing her nausea and vomiting with a medication called Zofran and prescription probiotics. Now, the US Food and Drug Administration has said they’ve received reports of stomach paralysis among patients taking the medications. “The FDA has received reports of gastroparesis with semaglutide and liraglutide, some of which documented the adverse event as not recovered after discontinuation of the respective product at the time of the report,” the agency said in a statement to CNN. However, officials clarified that they were unable to determine whether taking Ozempic or Wegovy was the cause of stomach paralysis, or if it was caused by a different issue. “Gastroparesis can be a complication of diabetes that is related to long-standing or poorly controlled disease, further complicating the ability to determine what role the drugs played in the reported events,” they said. As for whether patients should be warned about taking the drugs, the FDA maintained that taking the medications, such as for treating diabetes or weight management, may still “outweigh the risks in some patients with gastroparesis or delayed gastric emptying”. In response to reports of stomach paralysis, Novo Nordisk – the manufacturer behind Ozempic and Wegovy – noted that these drugs have been extensively studied in the real world and in clinical trials. “Gastrointestinal (GI) events are well-known side effects of the GLP-1 class,” the company told CNN. “For semaglutide, the majority of GI side effects are mild to moderate in severity and of short duration. GLP-1’s are known to cause a delay in gastric emptying, as noted in the label of each of our GLP-1 RA medications. Symptoms of delayed gastric emptying, nausea and vomiting are listed as side effects.” Last week, the American Society of Anesthesiologists also issued a warning that those who take GLP-1 agonists should avoid the medications a week before surgery because they may increase “risk of regurgitation and aspiration of food” while under anesthesia and deep sedation. Ozempic, a once-weekly injection used for the treatment of type 2 diabetes, has skyrocketed in use after people were reportedly prescribed the FDA-approved diabetes medication as an “off-label” weight loss drug. However, because of its increasing popularity, it has led to national shortages of the diabetes treatment - leaving those who actually need Ozempic without it. Meanwhile, Wegovy and Mounjaro are popular once-weekly semaglutide injections specifically approved for the treatment of obesity and weight loss. There are many side effects of taking medications like Ozempic, Wegovy, and Mounjaro. According to the FDA, the most common side effects of taking Wegovy are nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, dizziness, and digestive disorders. The FDA has also warned about more serious complications that can occur from use of Wegovy or Mounjaro, such as the “potential risk of thyroid C-cell tumours,” pancreatitis, gallbladder problems, acute kidney injury, increased heart rate, and suicidal behaviour or thinking. Taking Ozempic can also lead to possible thyroid tumours, including cancer, pancreatitis, changes in vision, and kidney and gallbladder problems. The Independent has contacted Novo Nordisk and the FDA for comment. Read More Clinics told to stop prescribing medicines as weight loss drug hits diabetes supply Influencer addresses ‘dangers’ of complimenting people’s bodies after weight loss comments Ozempic under EU investigation over reports of suicidal thoughts Mindy Kaling shuts down weight loss question as ‘people take it so personally’ What are weight loss injections and what’s the controversy? Raven Symone says people shouldn’t use Ozempic for ‘glamazon purposes’
2023-07-26 05:50
Miami Heat win Eastern Conference Finals Game 1 to steal homecourt advantage from the Boston Celtics
Miami Heat win Eastern Conference Finals Game 1 to steal homecourt advantage from the Boston Celtics
Jimmy Butler and the Miami Heat have continued their playoff hot streak with an impressive 123-116 road win against the Boston Celtics in Game 1 of the Eastern Conference Finals on Wednesday.
2023-05-18 18:02